Followers | 101 |
Posts | 13186 |
Boards Moderated | 0 |
Alias Born | 06/01/2013 |
Thursday, April 08, 2021 6:44:07 PM
https://www.forbes.com/sites/roberthart/2021/03/25/nasal-spray-of-covid-vaccine-may-be-next-oxford-reportedly-to-test-astrazeneca-version/?sh=384452d3310c
Research with laboratory animals suggests that a coronavirus infection can linger in the nose even after it has been vanquished in the lungs. That means it might be possible to spread the coronavirus after vaccination.
Nice video
https://www.scientificamerican.com/article/to-beat-covid-we-may-need-a-good-shot-in-the-nose/
The phase 1 trial, which could begin as early as next week, will involve about 30 healthy adults aged up to 40 © Marko Djurica/Reuters
https://www.ft.com/content/48fe2e97-f9e5-4291-b965-0728bfc42213
Oxford university has begun advertising for participants in an early-stage trial to deliver the Covid-19 vaccine it jointly developed with AstraZeneca as a nasal spray, according to documents seen by the Financial Times.
The phase 1 trial will involve about 30 healthy adults aged up to 40 and will study the safety of the formulation, according to a recruitment sheet circulated to prospective patients. It could begin as early as next week.
Participants will receive at least one intranasal dose of the vaccine. Half will be randomised to receive a booster dose. The study will take about four months to complete."
https://www.mumsnet.com/Talk/coronavirus/4203010-Nasal-spray-vaccine-trials
& Ronald Kempers ?
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM